Table 1. Age related anti-EBV antibodies in all patients visiting the PUMC Hospital, Beijing, 2013–2017.
| VCA IgG Pos no. (%) |
VCA IgM Pos no. (%) |
VCA IgA Pos no. (%) |
EA/D IgA Pos no. (%) |
EBNA1 IgG Pos no. (%) |
|
|---|---|---|---|---|---|
| 0–5y* | 283(66.59) | 65(14.57) | 52(14.57) | 26(7.12) | 141(58.51) |
| 6–10y | 431(84.34) | 55(10.24) | 93(22.79) | 39(9.18) | 226(78.75) |
| 11–20y | 784(92.89) | 123(10.41) | 178(23.73) | 95(12.20) | 413(86.95) |
| 21–30y | 809(98.54) | 88(6.25) | 192(26.10) | 120(15.33) | 271(95.43) |
| 31–40y | 853(98.84) | 40(3.06) | 219(22.71) | 123(11.80) | 203(94.86) |
| 41–50y | 892(99.78) | 36(2.76) | 282(22.54) | 171(13.13) | 202(97.57) |
| 51–60y | 957(99.79) | 37(2.62) | 301(27.54) | 184(15.79) | 248(96.12) |
| 61–101y | 902(99.01) | 29(2.03) | 258(33.42) | 146(18.36) | 258(93.82) |
| Male | 2905(94.23) | 229(5.13) | 864(25.62) | 504(14.31) | 938(86.93) |
| Female | 3006(95.58) | 244(5.35) | 711(24.03) | 400(12.76) | 1024(87.90) |
| Total | 5911(94.91) | 473(5.24) | 1575(24.87) | 904(13.58) | 1962(87.43) |
* Actual numbers of patients in each (age) groups tested for each parameter could be calculated from the positive numbers divided by their percentages.